Myeloma Paper of the Day, June 1st, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: MALT1 inhibition suppresses BCMA-induced NF-κB signaling and activates immunogenic cell death as part of its mechanism of action in pre-clinical both in vitro and in vivo models.”
Source: Robert Orlowski/X
Authors: Yao Yao, Mei Yuan, Min Shi, Wenyu Li, Yuqian Sha, Yan Zhang, Canli Yuan, Jianping Luo, Zhenyu Li, Chengcheng Liao, Kailin Xu, and Niu Mingshan.
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023